| dc.contributor.author | Márquez Coello, María de las Mercedes | |
| dc.contributor.author | Arizcorreta Yarza, Ana | |
| dc.contributor.author | Rodríguez Pardo, María | |
| dc.contributor.author | Illanes Álvarez, Francisco | |
| dc.contributor.author | Márquez, Denisse | |
| dc.contributor.author | Cuesta Sancho, Sara | |
| dc.contributor.author | Girón González, José Antonio | |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2021-09-09T09:36:07Z | |
| dc.date.available | 2021-09-09T09:36:07Z | |
| dc.date.issued | 2021-05 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | http://hdl.handle.net/10498/25327 | |
| dc.description.abstract | The objective of this work was to identify predictive factors of fibrosis regression after direct antiviral agents (DAAs) in HCV-monoinfected and HIV/HCV-coinfected patients. This was a prospective study of HCV-monoinfected (n=20), HIV/HCV-co-infected (n=66) patients and healthy controls (n=15). Patients had started DAAs and achieved sustained virological response. Liver stiffness (LS) and serum concentrations of profibrotic transforming growth factor (TGF)-beta 1 and CXC chemokine ligand 4 (CXCL4) and antifibrotic HGF hepatocyte growth factor (HGF) were analyzed at baseline (M0) and 12 months after starting DAAs (M12). A M12 LS achievement of <= 9.5 kPa was considered the cutoff point to discharge from a liver clinic. The LS decrease from M0 to M12 was 34%. No significant differences were observed in LS decline between HCV- and HIV/HCV-infected individuals. Changes of serum CXCL4, TGF-beta 1 and HGF levels did not correlate with LS improvement. 16 out from 56 patients (28%) with a baseline LS>9.5 achieved a M12 LS <= 9.5. HCV-monoinfected and HIV/HCV coinfected patients experienced a significant reduction of LS after sustained virological response. This improvement did not correlate with changes in serum profibrotic or antifibrotic markers. A 29% of those with a baseline LS>9.5 achieved a LS under this cutoff point. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | NATURE RESEARCH | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | Sci Rep 11, 9824 (2021) | es_ES |
| dc.title | Modifications of liver stiffness and CXCL4, TGF-beta 1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1038/s41598-021-89370-6 | |